In this issue:
Rituximab addition improves first-line chemo in follicular NHL
Combined front-line regimen improves APL survival
PK data/cytogenetic and molecular response in CML-CP
RCHOP - survival of indolent lymphoma in older patients
Thalidomide + prednisolone response in MM
Lack of survival differences in CLL4 examined
Cyclophosphamide + dexamethasone before ASCT
Dexamethasone/Thalidomide vs. VAD in myeloma
Allogeneic transplant in standard-risk ALL
Download PDF